NCT02202187View on ClinicalTrials.gov

A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 26, 2011

Primary Completion Date

February 15, 2012

Study Completion Date

February 15, 2012

Conditions

Infections, Respiratory Tract

Interventions

DRUG

GSK2140944

Investigational Study Drug

OTHER

Placebo

Placebo

Trial Locations (1)

55404

GSK Investigational Site, Minneapolis

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT02202187 - A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers | Biotech Hunter | Biotech Hunter